BioCentury
ARTICLE | Company News

sanofi-aventis, U.S. Department of Justice gastrointestinal news

September 17, 2007 7:00 AM UTC

SAN agreed to pay $182.8 million plus interest to settle a suit alleging that the company inflated the average wholesale price (AWP) for antiemetic drug Anzemet dolasetron, which federal health care ...